Feared Rules Save Research Time

File PhotoThe rush to put new rules in place for handling potentially dangerous materials in US laboratories last year put many in the research community on edge.Long before the prospect of bioterrorism became a national worry, scientists studying virulent pathogens had worked out safety standards to make sure the ugliest of bugs were not let loose on the public. The fear was that government regulators would add only more paperwork and costs to the process, getting in the way of research.Regulat

Written byPeg Brickley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

File Photo

The rush to put new rules in place for handling potentially dangerous materials in US laboratories last year put many in the research community on edge.

Long before the prospect of bioterrorism became a national worry, scientists studying virulent pathogens had worked out safety standards to make sure the ugliest of bugs were not let loose on the public. The fear was that government regulators would add only more paperwork and costs to the process, getting in the way of research.

Regulators like Charles Schable, director of the bioterrorism preparedness and response program at the National Center for Infectious Diseases, who have a background in research, are quick to agree. "Obviously, scientists that are handling the most dangerous organisms don't need select agent rules," Schable says. "They are going to be pretty careful."

The point of the select agent rules, he says, is to keep dangerous pathogens and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies